Firas Al-Niaimi

Medicine and Dentistry

1. Therapeutic Procedure 100%
2. Dermatology 66%
3. Rhinophyma 53%
4. Patient 39%
5. Injection 24%
6. Acneiform Eruption 23%
7. Skin 23%
8. Botulinum Toxin A 22%
9. Adverse Event 21%
10. Face 19%
11. Dermatological Disease 18%
12. Keloid 17%
13. Chloasma 17%
14. Verruca Vulgaris 17%
15. Botulinum Toxin 16%
16. Complication 16%
17. Acne Vulgaris 15%
18. Capillary 15%
19. Congenital Malformation 15%
20. Restylane 15%
21. Tissues 15%
22. Comprehension 14%
23. COVID-19 13%
24. Experience 13%
25. Monotherapy 12%
26. Erythema 11%
27. Azelaic Acid 11%
28. Age 9%
29. Recurrent Disease 9%
30. Diagnosis 9%
31. Hair Loss 9%
32. Drug Delivery 9%
33. Flushing 9%
34. Diseases 8%
35. Fluorouracil 8%
36. Capillary Hemangioma 8%
37. Satisfaction 8%
38. Cosmetics 8%
39. Etiology 8%
40. Scar 8%
41. Skin Type 8%
42. Hidradenitis Suppurativa 8%
43. Female 7%
44. Evidence-Based Medicine 7%
45. Consensus 7%
46. Cosmeceutical 7%
47. Dapsone 7%
48. Phototherapy 7%
49. Methotrexate 7%
50. Hydroquinone 7%